CRO Concept Stocks Decline: Hiteck Bio Down 11.24%, Tigermed Down 9.42%, Sino Biological Down 8.17%
CRO concept stocks continued to weaken in the latest trading session, with several names posting significant losses. As of the close, Hiteck Bio fell 11.24%, Tigermed dropped 9.42%, and Sino Biological declined 8.17%. Additionally, Novoprotein, OPM Biosciences, and Porton Pharma each fell more than 6%. The broad-based decline underscores persistent selling pressure across the contract research organization sector, with no individual stock in the group managing to avoid the downturn.
CRO concept stocks continued to weaken, with multiple stocks posting notable declines. As of the close, Hiteck Bio fell 11.24%, Tigermed fell 9.42%, and Sino Biological fell 8.17%. In addition, Novoprotein, OPM Biosciences, and Porton Pharma each declined more than 6%.